Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
Author:
Affiliation:
1. 1 Division of Internal Medicine and Hepato-Gastroenterology Unit; University Hospital; Ioannina Greece
2. Division of Hematology; Department of Internal Medicine; Medical School; University of Patras,; Patras Greece
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2011.02650.x/fullpdf
Reference46 articles.
1. Review article: blood platelet number and function in chronic liver disease and cirrhosis;Witters;Aliment Pharmacol Ther,2008
2. Thrombocytopenia associated with chronic liver disease;Afdhal;J Hepatol,2008
3. Abnormal hematological indices in cirrhosis;Qamar;Can J Gastroenterol,2009
4. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis;Qamar;Clin Gastroenterol Hepatol,2009
5. Predictors and implications of severe hypersplenism in patients with cirrhosis;Liangpunsakul;Am J Med Sci,2003
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic potential of rifaximin in liver diseases;Biomedicine & Pharmacotherapy;2024-09
2. Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): a Systematic review and meta-analysis;Annals of Hepatology;2024-09
3. Intermittent fasting, calorie restriction, and a ketogenic diet improve mitochondrial function by reducing lipopolysaccharide signaling in monocytes during obesity: A randomized clinical trial;Clinical Nutrition;2024-08
4. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease;World Journal of Hepatology;2024-01-27
5. Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3